Literature DB >> 2759798

Dexamethasone induces specific proteins in human trabecular meshwork cells.

C A Partridge1, B I Weinstein, A L Southren, M E Gerritsen.   

Abstract

Previous studies have demonstrated the presence of high-affinity, glucocorticoid-specific receptors in explants of human outflow tissue and in cultured trabecular meshwork. Glucocorticoid-induced responses of scleral fibroblasts and trabecular meshwork cells were evaluated in this study. Incubation of human trabecular meshwork (HTM) and scleral fibroblast (HS) cells with 10(-7) M dexamethasone (DEX) results in a 60% inhibition of prostaglandin production. The effects of glucocorticoid treatment on cellular and secreted proteins using [35S] methionine incorporation were evaluated. Treatment of HTM cells cultured from two normal individuals with DEX induced the expression of [35S] methionine-labelled cellular proteins of 35, 65 and 70 kD, and secreted proteins of 40, 90 and 100 kD. Under the same experimental conditions, a 70 kD molecular weight cellular protein was induced in the HS cells. There were no apparent DEX-induced alterations in HS-secreted proteins. Since a functional common response to glucocorticoid treatment in both HS and HTM cells was inhibition of prostaglandin production, the dexamethasone-induced expression of the 70 kD protein in these cells may be related to this effect. Further studies are required to elucidate specific roles of the steroid-induced proteins in the effects of glucocorticoids on HTM and HS cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759798

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular Hypertension.

Authors:  Shinwu Jeong; Nitin Patel; Christopher K Edlund; Jaana Hartiala; Dennis J Hazelett; Tatsuo Itakura; Pei-Chang Wu; Robert L Avery; Janet L Davis; Harry W Flynn; Geeta Lalwani; Carmen A Puliafito; Hussein Wafapoor; Minako Hijikata; Naoto Keicho; Xiaoyi Gao; Pablo Argüeso; Hooman Allayee; Gerhard A Coetzee; Mathew T Pletcher; David V Conti; Stephen G Schwartz; Alexander M Eaton; M Elizabeth Fini
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

Review 2.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

3.  Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro.

Authors:  Kandasamy Kathirvel; Karen Lester; Ravinarayanan Haribalaganesh; Ramasamy Krishnadas; Veerappan Muthukkaruppan; Brian Lane; David A Simpson; Kasia Goljanek-Whysall; Carl Sheridan; Devarajan Bharanidharan; Colin E Willoughby; Srinivasan Senthilkumari
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

4.  FOXC1 modulates MYOC secretion through regulation of the exocytic proteins RAB3GAP1, RAB3GAP2 and SNAP25.

Authors:  Alexandra Rasnitsyn; Lance Doucette; Morteza Seifi; Tim Footz; Vincent Raymond; Michael A Walter
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

5.  The LRRC8-mediated volume-regulated anion channel is altered in glaucoma.

Authors:  Xavier Gasull; Marta Castany; Aida Castellanos; Mikel Rezola; Alba Andrés-Bilbé; Maria Isabel Canut; Raúl Estévez; Teresa Borrás; Núria Comes
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.